Biosimilar Bevacizumab Market – Ophthalmology and...

added blog Health

2026-08-31 16:22:24 -

Market Overview The biosimilar bevacizumab market is expanding beyond oncology into ophthalmology, where intravitreal bevacizumab treats age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion at significantly lower cost than branded anti-VEGF ophthalmic agents. Off-label ophthalmic use of systemic bevacizumab has been compounded for eye injection, and biosimilars may...

0 Comments 0 Shares 192 Views 0 Reviews